HPV (genital wart) virus infection has been shown to be the causative agent for cancer of the cervix. There are at least 40 strains of the virus, but 2 strains account for about 70% of cases of cervical cancer. Infection is by skin to skin contact – it is thought that about 80 % of women will be infected with some form of wart virus. In most cases the infected persons body will eradicate the virus – however in some instances the infection persists and after a number of years cervical cancer can develop. Visible ‘warts’ are absent in most infections and there is no visible evidence of the infection.
Gardasil® is a new vaccine which protects against 4 strains of the virus, but, importantly, it protects against the strains which cause 70% of the cancers. Since the vaccine covers only 70% of the potential cervical cancer causing HPV infections, women must still have regular Cervical screening even though they have been immunised. The Gardasil Vaccine is not a live virus and reactions are uncommon – most frequent being minor injection site pain, headache, fever or nausea, however, the vaccine has not been proven to be effective nor shown to be safe in women over 26.
From the 1st January 2018 the gardasil vaccination will be replaced by the new Gardasil®9 vaccination. This will offer protection to 5 additional cancer causing strains of HPV virus (Strains 31, 33, 45, 52, and 58).
Gardasil®9 vaccine is free for Year 8 students as a 2 dose course under the School Immunisation Program. A 3 dose course is recommended for students who are immunocompromised or for those who start their course aged greater than 15 years.
In South Australia the school program commenced in April 2007 and was provided to girls in years 8 to 12. Boys between 9 and 15 years can also be vaccinated and since 1st February 2013, boys were also included in the free schools program. Children who miss out at school will be able to go to their doctor for immunisation. When not done under the free schools program, the Gardasil®9 vaccine costs approximately $150 per injection.
Those in the eligible age group who have already had genital warts or 'HPV infection' should still be vaccinated - because there are so many strains of the virus.
Gardasil® offers protection against four HPV types (6, 11, 16 and 18) and is recommended for men who have sex with men (MSM) who have not previously been vaccinated with three doses of HPV vaccine. Gardasil ® protects against the two high-risk HPV types (types 16 and 18), which cause 90% of all HPV-related cancers in men, it also protects against two low-risk HPV types (types 6 and 11), which cause 90% of genital warts.
Gardasil® vaccine is available for men aged 20 to 26 years as a 3 dose course until 31 July 2019. The first dose of the vaccine must be given prior to 1/5/19 to be eligible for the free vaccine.
Gardasil® is a new vaccine which protects against 4 strains of the virus, but, importantly, it protects against the strains which cause 70% of the cancers. Since the vaccine covers only 70% of the potential cervical cancer causing HPV infections, women must still have regular Cervical screening even though they have been immunised. The Gardasil Vaccine is not a live virus and reactions are uncommon – most frequent being minor injection site pain, headache, fever or nausea, however, the vaccine has not been proven to be effective nor shown to be safe in women over 26.
From the 1st January 2018 the gardasil vaccination will be replaced by the new Gardasil®9 vaccination. This will offer protection to 5 additional cancer causing strains of HPV virus (Strains 31, 33, 45, 52, and 58).
Gardasil®9 vaccine is free for Year 8 students as a 2 dose course under the School Immunisation Program. A 3 dose course is recommended for students who are immunocompromised or for those who start their course aged greater than 15 years.
In South Australia the school program commenced in April 2007 and was provided to girls in years 8 to 12. Boys between 9 and 15 years can also be vaccinated and since 1st February 2013, boys were also included in the free schools program. Children who miss out at school will be able to go to their doctor for immunisation. When not done under the free schools program, the Gardasil®9 vaccine costs approximately $150 per injection.
Those in the eligible age group who have already had genital warts or 'HPV infection' should still be vaccinated - because there are so many strains of the virus.
Gardasil® offers protection against four HPV types (6, 11, 16 and 18) and is recommended for men who have sex with men (MSM) who have not previously been vaccinated with three doses of HPV vaccine. Gardasil ® protects against the two high-risk HPV types (types 16 and 18), which cause 90% of all HPV-related cancers in men, it also protects against two low-risk HPV types (types 6 and 11), which cause 90% of genital warts.
Gardasil® vaccine is available for men aged 20 to 26 years as a 3 dose course until 31 July 2019. The first dose of the vaccine must be given prior to 1/5/19 to be eligible for the free vaccine.
For more information visit the SA Heath Website
The Vaccine:This vaccine is not a live virus.
Aged < 15yrs of age 2 doses of the vaccine are required, with the 2nd dose 6 to 12 months after the first one. Aged > 15yrs of age 3 doses of the vaccine are required, with the 2nd dose at 2 months and the 3rd dose 6 months after the first one. |
Recommended for:Children in Years 8 are provided this vaccination free through the Immunisation Schedule for Children.
Children who did not get the vaccination through the school programs can go to their GP but this will likely not be covered under the free school program and a fee will be charged. Gardasil vaccine should not be given to those with immediate allergy to yeast, those with phenylketonuria (PKU), in the presence of a high fever, during pregnancy (although no adverse outcomes have been reported) or where there has been an allergic reaction to a previous dose. Gardasil can be given while breast feeding but should not be given during pregnancy (although no adverse outcomes have been recorded). This vaccine is also recommended for:
|
Adverse Reactions:Adverse reactions are uncommon and usually minor:
|
